US Supreme Court issues Myriad Decision


The US Supreme Court has issued a comprimise ruling on the patenting of human genes. The Court ruled against certain claims of Myriad Genetics Inc. directed to naturally occurring human genes but upheld those for synthetically produced genetic materials. The genes concerned are linked to breast and ovarian cancer.

For more information, please contact Paul McKay.